Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TaiDoc TechnologyTPE:4736 +0.40%73 Return-on-Tangible-Equity is 15.70% as of Dec. 2025, which is 5% below its 10-year median of 16.50. GuruFocus rates TPE:4736 with a GF Score™ of 73/100 and a GF Value™ of NT$110.98 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 759 Medical Devices & Instruments companies, TaiDoc Technology ranks better than 77.87% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. TaiDoc Technology's annualized net income for the quarter that ended in Dec. 2025 was NT$1,505 Mil. TaiDoc Technology's average shareholder tangible equity for the quarter that ended in Dec. 2025 was NT$9,588 Mil. Therefore, TaiDoc Technology's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 15.70%.
The historical rank and industry rank for TaiDoc Technology's Return-on-Tangible-Equity or its related term are showing as below:
TPE:4736'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 10.96 Med: 16.5 Max: 39.69
Current: 16.01
During the past 13 years, TaiDoc Technology's highest Return-on-Tangible-Equity was 39.69%. The lowest was 10.96%. And the median was 16.50%.
TPE:4736's Return-on-Tangible-Equity is ranked better than 77.87% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.04
vs TPE:4736: 16.01
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
TaiDoc Technology Return-on-Tangible-Equity Related Terms
TaiDoc Technology Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for TaiDoc Technology's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TPE:4736 vs ABT, SYK, MDT: Return-on-Tangible-Equity Comparison
For the Medical Devices subindustry, TaiDoc Technology's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TaiDoc Technology Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, TaiDoc Technology's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where TaiDoc Technology's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 15.70% mean?
TaiDoc Technology (TPE:4736) has a Return-on-Tangible-Equity of 15.70% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on TaiDoc Technology and its competitors. This is near median its historical median of 16.50. Over the past decade, TaiDoc Technology's Return-on-Tangible-Equity has ranged from 10.96 to 39.69. According to the industry distribution chart, TaiDoc Technology ranks #168 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 22.1%.
Is TaiDoc Technology's Return-on-Tangible-Equity too high?
TaiDoc Technology's current Return-on-Tangible-Equity of 15.70% is near median its 10-year median of 16.50. Over the past 10 years, this metric has ranged from a low of 10.96 to a high of 39.69. The Medical Devices & Instruments industry median Return-on-Tangible-Equity is 4.04. TaiDoc Technology's value of 15.70% is 288.6% above this industry median. Based on the distribution chart, TaiDoc Technology ranks #168 out of 759 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, TaiDoc Technology has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TaiDoc Technology's Return-on-Tangible-Equity compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, TaiDoc Technology ranks #168 out of 759 companies for Return-on-Tangible-Equity. This places TaiDoc Technology in the top 22% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Equity is 4.04. TaiDoc Technology's value of 15.70% is 288.6% above this benchmark. Historically, TaiDoc Technology's own Return-on-Tangible-Equity has ranged from 10.96 to 39.69 over the past decade. While the company's 10-year median is 16.50 vs. the industry median of 4.04, TaiDoc Technology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.04, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TaiDoc Technology's current Return-on-Tangible-Equity of 15.70% is 288.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on TaiDoc Technology and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TaiDoc Technology's current Return-on-Tangible-Equity is 15.70%, which is near median its own 10-year median of 16.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TaiDoc Technology stock overvalued right now?
Based on GuruFocus' analysis, TaiDoc Technology (TPE:4736) is currently considered Modestly Overvalued. The stock's GF Value™ is NT$110.98, compared to a current price of NT$127.00 — trading 14.4% above its estimated fair value. The current Return-on-Tangible-Equity is 15.70%, which is near median its 10-year median of 16.50 and 288.6% above the Medical Devices & Instruments industry median of 4.04. TaiDoc Technology's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For TaiDoc Technology (TPE:4736), the current Return-on-Tangible-Equity is 15.70% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TaiDoc Technology (TPE:4736) Overvalued in 2026?
Based on GuruFocus' analysis, TaiDoc Technology stock appears to be overvalued.
The current stock price of NT$127.00 is trading 14.4% above its estimated GF Value™ of NT$110.98.
GuruFocus considers TaiDoc Technology to be Modestly Overvalued.
Key valuation signals for TPE:4736:
Return-on-Tangible-Equity: 15.70% (near median its 10-year median of 16.50)
GF Value™: NT$110.98 vs. price of NT$127.00 (14.4% above fair value)
Industry Position: 288.6% above the Medical Devices & Instruments median (#168 of 759)
No single metric tells the full story. See the TPE:4736 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TaiDoc Technology Corp is engaged in the research and development, manufacture, and sales of various electronics components and medical devices. Its products and services include In Vitro Diagnostic, Medical Device, and TeleHealth. It has three segments: Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from the Americas, the Middle East, Asia, Taiwan, and others.
73GF Score
Get the complete analysis for TPE:4736
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:4736 has been successfully added to your 
